Gotowa bibliografia na temat „Insulin metabolism”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Insulin metabolism”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Insulin metabolism"
Ukkola, O. "Ghrelin and insulin metabolism". European Journal of Clinical Investigation 33, nr 3 (marzec 2003): 183–85. http://dx.doi.org/10.1046/j.1365-2362.2003.01112.x.
Pełny tekst źródłaDuckworth, William C., Frederick G. Hamel i Daniel E. Peavy. "Hepatic metabolism of insulin". American Journal of Medicine 85, nr 5 (listopad 1988): 71–76. http://dx.doi.org/10.1016/0002-9343(88)90399-3.
Pełny tekst źródłaHeesom, K. J., M. Harbeck, C. R. Kahn i R. M. Denton. "Insulin action on metabolism". Diabetologia 40 (19.09.1997): S3—S9. http://dx.doi.org/10.1007/s001250051388.
Pełny tekst źródłaBeardsall, Kathryn, Barbro M. S. Diderholm i David B. Dunger. "Insulin and carbohydrate metabolism". Best Practice & Research Clinical Endocrinology & Metabolism 22, nr 1 (luty 2008): 41–55. http://dx.doi.org/10.1016/j.beem.2007.10.001.
Pełny tekst źródłaHeesom, K. J., M. Harbeck, C. R. Kahn i R. M. Denton. "Insulin action on metabolism". Diabetologia 40, S3 (marzec 1997): B3—B9. http://dx.doi.org/10.1007/bf03168179.
Pełny tekst źródłaHarned, Leighton Kahle, i Edward Chin. "PSUN278 Factitious hypoglycemia, diagnostic delay due to insulin assay failure to detect insulin analogues." Journal of the Endocrine Society 6, Supplement_1 (1.11.2022): A403. http://dx.doi.org/10.1210/jendso/bvac150.838.
Pełny tekst źródłaKagotho, Elizabeth. "Insulin-Mediated Glucose Metabolism: An Atherogenic Lipid Profile of Fructose Consumption". Endocrinology and Disorders 2, nr 2 (27.02.2018): 01–02. http://dx.doi.org/10.31579/2640-1045/096.
Pełny tekst źródłaKagotho, Elizabeth. "Insulin-Mediated Glucose Metabolism: An Atherogenic Lipid Profile of Fructose Consumption". Endocrinology and Disorders 2, nr 2 (15.02.2018): 01–02. http://dx.doi.org/10.31579/2640-1045/021.
Pełny tekst źródłaKusters, Yvo H. A. M., i Eugene J. Barrett. "Muscle microvasculature's structural and functional specializations facilitate muscle metabolism". American Journal of Physiology-Endocrinology and Metabolism 310, nr 6 (15.03.2016): E379—E387. http://dx.doi.org/10.1152/ajpendo.00443.2015.
Pełny tekst źródłaPiloquet, H., V. Ferchaud-Roucher, F. Duengler, Y. Zair, P. Maugere i M. Krempf. "Insulin effects on acetate metabolism". American Journal of Physiology-Endocrinology and Metabolism 285, nr 3 (wrzesień 2003): E561—E565. http://dx.doi.org/10.1152/ajpendo.00042.2003.
Pełny tekst źródłaRozprawy doktorskie na temat "Insulin metabolism"
Vidal, Alabró Anna. "Estudi de l’activació de la glucocinasa (GKA456V) en fetge perivenós". Doctoral thesis, Universitat de Barcelona, 2011. http://hdl.handle.net/10803/32022.
Pełny tekst źródłaSynthetic glucokinase activators have been used in the context of type 2 diabetes therapy, mainly for their insulin secretagogue activity. However, the impact of these drugs on liver GK has not been studied in vivo. Since GK activators and activating GK mutations confer identical kinetic properties to GK, we hypothesize that hepatic overexpression of a mutated form of GK, GKA456V, described in a patient with Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI), shall mimic the liver-specific effects of GK-activating drugs. GKA456V was overexpressed in the liver of streptozotocin diabetic mice and also in healthy mice. Metabolite profiling in serum and liver extracts, together with key components of glucose and lipid homeostasis, were analyzed and compared to GK wild-type transfected animals. Cell compartmentalization of mutant and wild-type GK was also examined in vivo. In the type 1 diabetic mice, GKA456V overexpression markedly reduced blood glucose in the absence of dislipidemia, in contrast to wild-type GK-overexpressing mice. Enhanced glucose utilization did not correlate with glycogen synthesis or lactate production. PEPCK mRNA was not affected, whereas the mRNA for the catalytic subunit of glucose-6-phosphatase was upregulated ~4-fold in the liver of GKA456V treated animals. Moreover, GKA456V was not translocated to the nucleus after a short fast, confirming that this activating mutation disrupted GKRP regulation. In healthy mice, the overexpression of hepatic GK resulted in insulin resistance. Otherwise, GKA456V overepxressing animals were not insulin resistant. They showed increased mRNA and protein content of the catalytic subunit of glucose-6-phosphatase in the liver, and an idnuction of catabolism in their adipose tissue. Our results validate liver specific GK activation as a strategy for diabetes therapy and provide new insights into the complex GK regulatory network.
Collison, Mary Williamson. "Insulin signalling in insulin resistance and cardiovascular disease syndromes". Thesis, University of Glasgow, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.366184.
Pełny tekst źródłaKershner, David. "Oral Glucose Insulin Secretion Test for Identifying Patients with Insulin Resistance". ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5634.
Pełny tekst źródłaMashhedi, Haider. "Implicating insulin in neoplastic growth and metabolism". Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=104681.
Pełny tekst źródłaCompte tenu de l'accumulation de preuves liant l'obésité à un nombre accru de cancers, il y a un grand intérêt à définir les mécanismes par lesquels l'obésité influe sur la croissance néoplasique. Des niveaux d'insuline élevés sont couramment associés à l'obésité ou au «syndrome métabolique», ce qui fait que le récepteur de l'insuline est considéré comme une cible moléculaire potentiellement importante pour le traitement de certains cancers. Pour étudier les effets de l'atténuation de la signalisation de l'insuline sur la croissance du modèle expérimental du cancer du sein chez la souris, la lignée cellulaire insulino-sensible 4T1 in vivo, nous avons comparé les effets d'une déficience à l'insuline induite par l'alloxan à celle de BMS-536924, un inhibiteur des kinases tyrosine des récepteurs de l'insuline et d'IGF-I. Les deux interventions ont montré une activité anti-néoplasique, mais seulement l'alloxan a présenté une toxicité métabolique. L'inhibition des récepteurs d'insuline n'a occasionné qu'une faible hyperglycémie et le traitement avec BMS-536924 a été bien toléré. Nous avons attribué ce phénomène à des facteurs pharmacocinétiques en mesurant l'accumulation de drogue dans les tissus et pour déterminer si le BMS-536924 abolit l'absorption insulino-dépendante du glucose, nous avons mesuré la quantité de glucose utilisé dans le muscle. Nos données indiquent que la captation insulino-dépendante du glucose par le muscle est restée intacte. Ainsi, la distribution tissu-spécifique du BMS-536924 peut être responsable de l'activité anti-néoplasique sans toxicité métabolique grave, ce qui indique que le ciblage pharmacologique du récepteur de l'insuline dans la maladie néoplasique peut être efficace.Les études épidémiologiques ont montré que les patients diabétiques de type II prenant le médicament metformine (un biguanide) ont un risque réduit de développer un cancer ou d'un taux de mortalité due au cancer plus faible par rapport aux patients diabétiques de type II suivant d'autres thérapies. Nous avons déjà montré que la metformine agit comme un inhibiteur de la croissance des cellules tumorales in vitro en phosphorylant l'AMPK d'une manière dépendante de la dose. Outre l'activation de l'AMPK, qui est observée dans les cellules tumorales in vitro et in vivo, la metformine provoque aussi une diminution des taux d'insuline. Ceci est un effet secondaire de la réduction du taux de glycémie dans un contexte de diabète de type II. La tomographie par émission de positons (TEP ou PET) est une technique d'imagerie qui mesure le taux d'utilisation du glucose par les cellules cancéreuses à l'aide de l'analogue du glucose radiomarqué 18F-2-Fluoro-2-Désoxy-D-Glucose (FDG). Nous étions intéressés par les effets de la metformine sur la captation du glucose par les tumeurs d'adénocarcinome de côlon, MC38, allogreffées chez des souris qui ont été nourris avec une diète à haute teneur énergétique (induisant un phénotype diabétique de type II), ou un régime contrôle. Nos résultats montrent que la metformine abolie l'augmentation des niveaux sériques d'insuline, l'activation du récepteur d'insuline dans les tumeurs ainsi que l'absorption du FDG par les tumeur chez les souris ayant un régime riche en énergie et que la metformine n'a aucun effet sur ces mesures chez les souris ayant une diète contrôle. Ceci suggère que pour un sous-ensemble de néoplasmes, le régime alimentaire et le taux d'insuline influencent l'absorption du glucose par les cellules tumorales ce qui pourrait avoir une pertinence clinique dans les prochaines études clinique visant l'évaluation de l'activité anti-néoplasique de la metformine.
Shmueli, Ehoud. "Glucose metabolism and insulin resistance in cirrhosis". Thesis, University of Newcastle Upon Tyne, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.308777.
Pełny tekst źródłaLaberge, Marie-Kristine. "Nck1 is required for ER stress-induced insulin resistance and regulation of IRS1-dependent insulin signalling". Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=111950.
Pełny tekst źródłaSanderson, Alison Louise. "Regulation of skeletal muscle metabolism". Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.318615.
Pełny tekst źródłaField, Polly Ann. "The effects of insulin resistance on chylomicron metabolism". Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.302120.
Pełny tekst źródłaDeAngelis, Anthony Michael. "CEACAM1 : a link between insulin and lipid metabolism". Connect to full text in OhioLINK ETD Center, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=mco1243943993.
Pełny tekst źródła"In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences." Title from title page of PDF document. Bibliography: p. 57-61, p. 20-145.
Nygren, Jonas. "The sites and mechanisms of postoperative insulin resistance /". Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2695-6.
Pełny tekst źródłaKsiążki na temat "Insulin metabolism"
Markussen, Jan. Human insulin by tryptic transpeptidations of porcine insulin and biosynthetic procursors. Lancaster: MTP Press, 1987.
Znajdź pełny tekst źródłaHuman insulin by tryptic transpeptidations of porcine insulin and biosynthetic precursors. Lancaster: MTP Press, 1987.
Znajdź pełny tekst źródłaInternational Conference on Insulin Action and Diabetes (1987 Calgary, Alta.). Insulin action and diabetes. Redaktorzy Goren H. Joseph, Hollenberg Morley D. 1942- i Roncari Daniel A. K. New York: Raven Press, 1988.
Znajdź pełny tekst źródłaEuropean Symposium on Metabolism (8th 2002 Padua, Italy). The metabolic syndrome: Diabetes, obesity, hyperlipidemia & hypertension : proceedings of the 8th European Symposium on Metabolism, held in Padua, Italy, between 2 and 5 October 2002. Redaktorzy Crepaldi Gaetano, Tiengo Antonio i Avogaro Angelo. Amsterdam: Elsevier, 2003.
Znajdź pełny tekst źródłaKraicer, P. Ṿisut ha-energyah ba-guf: Pereḳ be-endoḳrinologyah. [Tel Aviv]: Maṭkal/Ḳetsin ḥinukh rashi/Gale-Tsahal, Miśrad ha-biṭaḥon, 1985.
Znajdź pełny tekst źródłaTrumbach, Sabine. Glukose-Toleranz und Insulin-Sekretion unter simulierter Schwerelosigkeit. Koln: DFLVR, 1988.
Znajdź pełny tekst źródłaInternational Smolenice Insulin Symposium (2nd 1992). Dietary lipids and insulin action. New York, N.Y: New York Academy of Sciences, 1993.
Znajdź pełny tekst źródłaEuropean Symposium on Metabolism (6th 1993 Padua, Italy). Diabetes, obesity, and hyperlipidemias, V: The plurimetabolic syndrome : proceedings of the European Symposium on Metabolism, Padova, 24-26 May 1993. Redaktorzy Crepaldi Gaetano, Tiengo Antonio i Manzato E. Amsterdam: Excerpta Medica, 1993.
Znajdź pełny tekst źródłaDorrestijn, Jannette. Signal transduction related to the metabolic action of insulin. [Leiden: University of Leiden, 1998.
Znajdź pełny tekst źródłaInternational Symposium on Insulin Action and Its Disorders (1990 Ōtsu-shi, Japan). Recent advances in insulin action and its disorders: Proceedings of the International Symposium on Insulin Action and Its Disorders, Shiga, 16 May 1990. Redaktorzy Shigeta Yukio 1929-, Kobayashi Masashi Dr i Olefsky Jerrold M. Amsterdam: Excerpta Medica, 1991.
Znajdź pełny tekst źródłaCzęści książek na temat "Insulin metabolism"
Larner, J. "Effects of Insulin on Glycogen Metabolism". W Insulin, 367–84. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74098-5_16.
Pełny tekst źródłaBressler, R., i J. J. Bahl. "Insulin Regulation of Metabolism Relevant to Gluconeogenesis". W Insulin, 451–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74098-5_20.
Pełny tekst źródłaFrayn, Keith N., i Fredrik Karpe. "Insulin Action on Lipid Metabolism". W Insulin Resistance, 87–103. Chichester, UK: John Wiley & Sons, Ltd, 2005. http://dx.doi.org/10.1002/0470011327.ch3.
Pełny tekst źródłaKonrad, Daniel, Assaf Rudich i Amira Klip. "Insulin-Mediated Regulation of Glucose Metabolism". W Insulin Resistance, 63–85. Chichester, UK: John Wiley & Sons, Ltd, 2005. http://dx.doi.org/10.1002/0470011327.ch2.
Pełny tekst źródłaHileman, Stanley M., i Christian Bjørbaek. "Central Regulation of Peripheral Glucose Metabolism". W Insulin Resistance, 179–206. Chichester, UK: John Wiley & Sons, Ltd, 2005. http://dx.doi.org/10.1002/0470011327.ch7.
Pełny tekst źródłaGreenlund, Laura J. S., i K. Sreekumaran Nair. "The Effect of Insulin on Protein Metabolism". W Insulin Resistance, 105–32. Chichester, UK: John Wiley & Sons, Ltd, 2005. http://dx.doi.org/10.1002/0470011327.ch4.
Pełny tekst źródłaMathias, Dietger. "Metabolism and Insulin Effect". W Fit and Healthy from 1 to 100 with Nutrition and Exercise, 143. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-65961-8_67.
Pełny tekst źródłaPatnaik, Akash, Jason W. Locasale i Lewis C. Cantley. "Cancer Cell Metabolism". W Insulin-like Growth Factors and Cancer, 245–61. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-0598-6_13.
Pełny tekst źródłaGuest, Paul C. "Insulin Resistance in Schizophrenia". W Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders, 1–16. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-12668-1_1.
Pełny tekst źródłaCarmena, R., J. F. Ascaso, A. Merchante i F. J. Ampudia. "Insulin Resistance and Lipid Disorders". W Drugs Affecting Lipid Metabolism, 379–88. Dordrecht: Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0311-1_44.
Pełny tekst źródłaStreszczenia konferencji na temat "Insulin metabolism"
Senhorinha, Gláucia Maria, Arlys Emanuel Mendes da Silva Santos i Douglas Daniel Dophine. "The role of metabolic syndrome in Alzheimer’s disease". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.319.
Pełny tekst źródłaEl-fadl, Rihab, Nasser Rizk, Amena Fadel i Abdelrahman El Gamal. "The Profile of Hepatic Gene Expression of Glucose Metabolism in Mice on High Fat Diet". W Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0213.
Pełny tekst źródłaRad, Milad Ghiasi, Aditya Immaneni, Megan McCabe, Massimiliano Pierobon i Juan Cui. "A simulation model of glucose-insulin metabolism and implementation on OSG". W 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2017. http://dx.doi.org/10.1109/bibm.2017.8217939.
Pełny tekst źródłaStaal, Odd Martin, Anders Lyngvi Fougner, Steinar Saelid i Oyvind Stavdahl. "Glucose-insulin metabolism model reduction and parameter selection using sensitivity analysis". W 2019 American Control Conference (ACC). IEEE, 2019. http://dx.doi.org/10.23919/acc.2019.8814949.
Pełny tekst źródłaWardelmann, K., M. Rath, JP Castro, S. Blümel, M. Schell, R. Hauffe, C. Chudoba i in. "Central acting Hsp10 regulates mitochondrial function, insulin sensitivity and impacts liver metabolism". W Diabetes Kongress 2021 – 55. Jahrestagung der DDG. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1727356.
Pełny tekst źródłaCampos, L. M., A. G. Rius, D. Kirovski, J. A. D. R. N. Appuhamy, T. F. V. Bompadre i M. D. Hanigan. "Mammary gland amino acid affinity in response to different levels of dietary protein and insulin". W 6th EAAP International Symposium on Energy and Protein Metabolism and Nutrition. The Netherlands: Wageningen Academic Publishers, 2019. http://dx.doi.org/10.3920/978-90-8686-891-9_120.
Pełny tekst źródłaDiniz, Clebiana Alves e. silva, Poliana Silva de Brito, Tainan de Andrade Rocha, Suzana Maria de Oliveira Costa Meneses i Julia Maria Pacheco Lins Magalhães. "Elderly people with diabetes: an analysis of the factors that are associated with lower limb amputation". W II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-028.
Pełny tekst źródłaMougiakakou, Stavroula G., Aikaterini Prountzou, Dimitra Iliopoulou, Konstantina S. Nikita, Andriani Vazeou i Christos S. Bartsocas. "Neural Network based Glucose - Insulin Metabolism Models for Children with Type 1 Diabetes". W Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.260640.
Pełny tekst źródłaMougiakakou, Stavroula G., Aikaterini Prountzou, Dimitra Iliopoulou, Konstantina S. Nikita, Andriani Vazeou i Christos S. Bartsocas. "Neural Network based Glucose - Insulin Metabolism Models for Children with Type 1 Diabetes". W Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.4398212.
Pełny tekst źródłaĐokovic, Radojica, Marko Cincovic, Vladimir Kurćubic, Milun D. Petrovic, Miloš Ži Petrovic, Ljiljana Anđušic i Biljana Anđelic. "HOMEORETSKA REGULACUJA METABOLIČKIH FUNKCIJA KOD KRAVA U PERIPARTALNOM PERIODU". W SAVETOVANJE o biotehnologiji sa međunarodnim učešćem. University of Kragujevac, Faculty of Agronomy, 2021. http://dx.doi.org/10.46793/sbt26.235dj.
Pełny tekst źródłaRaporty organizacyjne na temat "Insulin metabolism"
Gao, Hui, Chen Gong, Shi-chun Shen, Jia-ying Zhao, Dou-dou Xu, Fang-biao Tao, Yang Wang i Xiao-chen Fan. A systematic review on the associations between prenatal phthalate exposure and childhood glycolipid metabolism and blood pressure: evidence from epidemiological studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, czerwiec 2022. http://dx.doi.org/10.37766/inplasy2022.6.0111.
Pełny tekst źródłaResearch, Gratis. Brown Fat Activation: A Future Treatment for Obesity & Diabetes. Gratis Research, listopad 2020. http://dx.doi.org/10.47496/gr.blog.01.
Pełny tekst źródłaBoisclair, Yves R., i Arieh Gertler. Development and Use of Leptin Receptor Antagonists to Increase Appetite and Adaptive Metabolism in Ruminants. United States Department of Agriculture, styczeń 2012. http://dx.doi.org/10.32747/2012.7697120.bard.
Pełny tekst źródłaLekhanya, Portia Keabetswe, i Kabelo Mokgalaboni. Exploring the effectiveness of vitamin B12 complex and alpha-lipoic acid as a treatment for diabetic neuropathy. Protocol for systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0167.
Pełny tekst źródłayu, luyou, jinping yang, xi meng i yanhua lin. Effectiveness of the gut microbiota-bile acid pathway (BAS) in the treatment of Type 2 diabetes: A protocol for systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0117.
Pełny tekst źródłaMeidan, Rina, i Robert Milvae. Regulation of Bovine Corpus Luteum Function. United States Department of Agriculture, marzec 1995. http://dx.doi.org/10.32747/1995.7604935.bard.
Pełny tekst źródłaMcGuire, Mark A., Amichai Arieli, Israel Bruckental i Dale E. Bauman. Increasing Mammary Protein Synthesis through Endocrine and Nutritional Signals. United States Department of Agriculture, styczeń 2001. http://dx.doi.org/10.32747/2001.7574338.bard.
Pełny tekst źródłaButler, Walter R., Uzi Moallem, Amichai Arieli, Robert O. Gilbert i David Sklan. Peripartum dietary supplementation to enhance fertility in high yielding dairy cows. United States Department of Agriculture, kwiecień 2007. http://dx.doi.org/10.32747/2007.7587723.bard.
Pełny tekst źródła